As biomanufacturing capacity becomes strained, several new methods for producing biologics are being investigated by biotechnology companies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Versatile and on-demand biologics co-production in yeast
Nature Communications Open Access 08 January 2018
-
Expression of Histophilus somni IbpA DR2 protective antigen in the diatom Thalassiosira pseudonana
Applied Microbiology and Biotechnology Open Access 12 April 2017
-
Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
Nature Communications Open Access 29 July 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Dove, A. Uncorking the biomanufacturing bottleneck. Nat Biotechnol 20, 777–779 (2002). https://doi.org/10.1038/nbt0802-777
Issue Date:
DOI: https://doi.org/10.1038/nbt0802-777
This article is cited by
-
Versatile biomanufacturing through stimulus-responsive cell–material feedback
Nature Chemical Biology (2019)
-
Versatile and on-demand biologics co-production in yeast
Nature Communications (2018)
-
Expression of Histophilus somni IbpA DR2 protective antigen in the diatom Thalassiosira pseudonana
Applied Microbiology and Biotechnology (2017)
-
Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
Nature Communications (2016)
-
The transgenic animal platform for biopharmaceutical production
Transgenic Research (2016)